[go: up one dir, main page]

BE1002436A3 - Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments. Download PDF

Info

Publication number
BE1002436A3
BE1002436A3 BE8800545A BE8800545A BE1002436A3 BE 1002436 A3 BE1002436 A3 BE 1002436A3 BE 8800545 A BE8800545 A BE 8800545A BE 8800545 A BE8800545 A BE 8800545A BE 1002436 A3 BE1002436 A3 BE 1002436A3
Authority
BE
Belgium
Prior art keywords
pyrannopyridines
pyrans
medicaments
preparation
novel benzo
Prior art date
Application number
BE8800545A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002436A3 publication Critical patent/BE1002436A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention a pour objet les benzo(b)pyrannes et pyrannopyridines de formule dans laquelle V, T, W, R3 à R5, R9, R10, m, X, Y et Z signifient des restes variés, et leurs N-oxydes et leurs sels. Ces composés peuvent être utilisés comme médicaments.
BE8800545A 1987-05-16 1988-05-17 Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments. BE1002436A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3716523 1987-05-16

Publications (1)

Publication Number Publication Date
BE1002436A3 true BE1002436A3 (fr) 1991-02-12

Family

ID=6327752

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800545A BE1002436A3 (fr) 1987-05-16 1988-05-17 Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments.

Country Status (21)

Country Link
US (1) US5071871A (fr)
JP (1) JPS63303977A (fr)
KR (1) KR880013915A (fr)
AT (1) ATA125188A (fr)
AU (1) AU614285B2 (fr)
BE (1) BE1002436A3 (fr)
CA (1) CA1312866C (fr)
CH (1) CH674984A5 (fr)
DK (1) DK265188A (fr)
ES (1) ES2012527A6 (fr)
FI (1) FI882248A (fr)
FR (1) FR2615191B1 (fr)
GB (1) GB2204868B (fr)
HU (1) HU203336B (fr)
IL (1) IL86376A0 (fr)
IT (1) IT1219940B (fr)
NL (1) NL8801258A (fr)
NZ (1) NZ224604A (fr)
PT (1) PT87492B (fr)
SE (1) SE467924B (fr)
ZA (1) ZA883450B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (fr) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Dérivés de chromane
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5239090A (en) * 1989-02-01 1993-08-24 Beecham Group P.L.C. Certain optically active 3,4-dihydrobenzopyran-4-ols which are intermediates
GB8902118D0 (en) * 1989-02-01 1989-03-22 Beecham Group Plc Chemical process
US5066816A (en) * 1989-03-03 1991-11-19 Yoshitomi Pharmaceutical Industries, Ltd. Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2h-1-benzopyran compounds and intermediates therefor
US5162553A (en) * 1989-03-03 1992-11-10 Yoshitomi Pharmaceutical Industries, Ltd. Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds and intermediates therefor
GB8911949D0 (en) * 1989-05-24 1989-07-12 Beecham Group Plc Novel compounds
US5232938A (en) * 1989-05-24 1993-08-03 Beecham Group P.L.C. Certain 1,2,4-triazole(oxy or amino)benzopyran derivatives having pharmacological activity
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
GB8915315D0 (en) * 1989-07-04 1989-08-23 Sandoz Ltd Pharmaceutical compositions for use against hypertension and congestive heart failure
US5223629A (en) * 1989-07-21 1993-06-29 Alkaloida Vegyeszeti Gyar Process for the preparation of anti-hypertensive benzopyran
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
DE3926001A1 (de) * 1989-08-05 1991-02-07 Merck Patent Gmbh Chromanderivate
DE3933663A1 (de) * 1989-10-09 1991-04-11 Merck Patent Gmbh Chromanderivate
US5232944A (en) * 1989-10-09 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
DE3936616A1 (de) * 1989-11-03 1991-05-08 Merck Patent Gmbh Verfahren zur enantiomerentrennung von benzopyranderivaten
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
BE1004295A3 (fr) * 1990-05-17 1992-10-27 Sandoz Sa Utilisation des activateurs des canaux potassiques pour la prophylaxie de l'asthme.
DE4038752A1 (de) * 1990-12-05 1992-06-11 Merck Patent Gmbh Chromanderivate
JP3255411B2 (ja) * 1991-02-18 2002-02-12 中外製薬株式会社 発毛促進剤
US5291890A (en) * 1991-08-29 1994-03-08 General Electric Company Magnetic resonance surgery using heat waves produced with focussed ultrasound
US5206252A (en) * 1992-05-08 1993-04-27 American Home Products Corporation Thiadiazolyl-amino derivatives of benzopyrans and indanes
EP0655448B1 (fr) * 1992-08-17 2000-04-12 Chugai Seiyaku Kabushiki Kaisha Derives de benzopyranne et de benzoxazine
SI0714395T1 (en) * 1993-08-19 1999-08-31 Janssen Pharmaceutica N.V. Vasoconstrictive substituted dihydropyranopyridines
US5368031A (en) * 1993-08-29 1994-11-29 General Electric Company Magnetic resonance surgery using heat waves produced with a laser fiber
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
WO1995013272A1 (fr) * 1993-11-10 1995-05-18 Japan Tobacco Inc. Derive de chromanne et utilisation therapeutique de ce dernier
US5482942A (en) * 1994-06-28 1996-01-09 American Home Products Corporation (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
AU7319800A (en) * 1999-09-24 2001-04-24 Nissan Chemical Industries Ltd. 4-oxybenzopyran derivative
EP1218367A1 (fr) * 1999-10-05 2002-07-03 Nissan Chemical Industries, Ltd. Derive de 4-oxybenzopyranne
EP2328574A1 (fr) * 2008-08-05 2011-06-08 University College Cork-National University of Ireland, Cork Traitement de la dégénérescence de la rétine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2526428A1 (fr) * 1982-05-06 1983-11-10 Erba Farmitalia Iminoderives substitues du 4h-2,3-dihydrobenzopyranne et du 4h-2,3-dihydrobenzothiopyranne, leur procede de preparation et leur utilisation comme depresseurs du systeme nerveux central
EP0205292A2 (fr) * 1985-06-08 1986-12-17 Beecham Group Plc Dérivés de pyrano[3,2-c] pyridine, procédé et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391815A (en) * 1976-04-02 1983-07-05 Beecham Group Limited Cyanobenzano[b]pyrans
EP0107423B1 (fr) * 1982-10-19 1986-07-23 Beecham Group Plc Chromanes et chromènes
GB8308063D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
GB8308062D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
DE3732146A1 (de) * 1987-09-24 1989-04-06 Merck Patent Gmbh Azachromanderivate
CA1327574C (fr) * 1987-12-22 1994-03-08 Toshio Tatsuoka Compose servant a corriger l'insuffisance cerebrale

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2526428A1 (fr) * 1982-05-06 1983-11-10 Erba Farmitalia Iminoderives substitues du 4h-2,3-dihydrobenzopyranne et du 4h-2,3-dihydrobenzothiopyranne, leur procede de preparation et leur utilisation comme depresseurs du systeme nerveux central
EP0205292A2 (fr) * 1985-06-08 1986-12-17 Beecham Group Plc Dérivés de pyrano[3,2-c] pyridine, procédé et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ES2012527A6 (es) 1990-04-01
FI882248A (fi) 1988-11-17
GB2204868B (en) 1991-05-22
IL86376A0 (en) 1988-11-15
AU1615888A (en) 1988-11-17
SE8801807L (sv) 1988-11-17
FI882248A0 (fi) 1988-05-13
KR880013915A (ko) 1988-12-22
SE467924B (sv) 1992-10-05
GB2204868A (en) 1988-11-23
ZA883450B (en) 1990-01-31
ATA125188A (de) 1993-06-15
FR2615191B1 (fr) 1991-01-11
JPS63303977A (ja) 1988-12-12
DK265188A (da) 1988-11-17
IT8847956A0 (it) 1988-05-13
US5071871A (en) 1991-12-10
IT1219940B (it) 1990-05-24
PT87492A (pt) 1989-05-31
NL8801258A (nl) 1988-12-16
GB8811359D0 (en) 1988-06-15
CA1312866C (fr) 1993-01-19
AU614285B2 (en) 1991-08-29
HU203336B (en) 1991-07-29
DK265188D0 (da) 1988-05-13
CH674984A5 (fr) 1990-08-15
HUT50151A (en) 1989-12-28
NZ224604A (en) 1991-04-26
FR2615191A1 (fr) 1988-11-18
SE8801807D0 (sv) 1988-05-13
PT87492B (pt) 1992-09-30

Similar Documents

Publication Publication Date Title
BE1002436A3 (fr) Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments.
FR2405934A1 (fr) Nouvelles 4-thio-2-oxo azetidines utiles dans la synthese de medicaments
DK77090D0 (da) Immunmodulerende azaspiraner
FR2371436A1 (fr) Nouveaux derives de morpholine ou de piperidine utiles comme medicaments et comme fongicides
BE898880A (fr) Nouveaux benzimidazoles, preparations pharmaceutiques qui les contiennent et leur preparation
BE1002213A5 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
FR2381763A1 (fr) Dibenzo(b-e) (diazepines-1,4) et leur utilisation comme antischizophreniques
FR2444681A1 (fr) Nouvelles 1,4-dihydropyridines, leur preparation et leur application comme medicaments
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
FR2365567A1 (fr) Nouvelles piperazinylpyridines utiles comme medicaments
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
BE1002151A5 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments.
FR2361370A1 (fr) Nouvelles pyridines substituees, leur preparation et leur application comme medicaments
FR2388795A1 (fr) Nouveaux n-(1-(3-benzoylpropyl)-4-piperidyl)-sulfamides, procedes pour leur preparation et medicaments les renfermant
FR2361880A1 (fr) Nouvelles 4-amino piperidines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2417502A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2401147A1 (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6, utiles comme intermediaires chimiques dans la synthese de medicaments
FR2379533A1 (fr) Tetrazolylcarbamoylquinoleines utilisables comme medicaments et leur preparation
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2417503A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2358890A1 (fr) Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
BE1002286A4 (fr) Nouveaux composes heterocycliques, leur preparation et leur utilisation comme herbicides.
FR2412563A1 (fr) 2-desoxyfortimicine a et derives 4-n-alkyl et 4-n-acyl-2-desoxyfortimicine b, utiles notamment comme antibiotiques, et intermediaires pour leur preparation
FR2377382A1 (fr) Nouveaux phenylazacycloalcanes utiles comme medicaments
FR2382431A1 (fr) Nouvelles 2-hydroxy-propylamines, leur preparation et leur utilisation comme agents tensio-actifs

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19930531